Hims Launches Compounded GLP-1 Pill, CVS Forces Biosimilars – This Week in Biotech #88

from Biotech Blueprint · host Katerina Roznik

Compounded semaglutide draws FDA scrutiny as Novo Nordisk guides 2026 lower and Eli Lilly leans into a $50 Medicare copay (Jan 30-Feb 5, 2026).Follow Biotech Blueprint at biotechblueprint.com.

Episode metadata supplied by the publisher feed · Published Feb 6, 2026

Embed this episode

Attribution link and audio player

Ready to play

Hims Launches Compounded GLP-1 Pill, CVS Forces Biosimilars – This Week in Biotech #88

0:00 6:05

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Biotech Blueprint?

This episode is 6 minutes long.

When was this Biotech Blueprint episode published?

This episode was published on February 6, 2026.

Can I download this Biotech Blueprint episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!